Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.80% | 35.74% | 9.72% | 46.20% | -43.36% |
| Total Depreciation and Amortization | -3.91% | 0.89% | 6.34% | 8.94% | 8.25% |
| Total Amortization of Deferred Charges | -43.20% | -62.80% | -72.31% | -64.54% | -52.38% |
| Total Other Non-Cash Items | -85.68% | -76.32% | -81.07% | -95.30% | 11.05% |
| Change in Net Operating Assets | -1,313.96% | -648.68% | 36.72% | 385.51% | -123.32% |
| Cash from Operations | -19.40% | -704.07% | -871.24% | -265.40% | -168.42% |
| Capital Expenditure | 54.86% | 56.65% | 58.14% | 60.23% | 54.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 98.06% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -100.00% | -88.97% | -93.89% |
| Cash from Investing | 75.54% | 70.57% | -29.15% | -5.99% | -3.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -26.69% | 76.49% | 97.84% | -3,779.70% | -3,802.32% |
| Issuance of Common Stock | 218.85% | 218.85% | 218.85% | -- | 374.36% |
| Repurchase of Common Stock | -25.28% | -9,940.43% | -218.85% | -157.73% | -161.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -269.48% | -62.43% | -766.49% | -254.36% | -152.92% |
| Cash from Financing | 32.07% | 72.16% | 93.00% | -26,591.24% | -26,355.59% |
| Foreign Exchange rate Adjustments | 239.47% | -202.74% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.27% | 56.94% | 58.22% | -23,006.56% | -4,229.25% |